FDA issues emergency use authorization for second at-home COVID-19 treatment
For the second time in as many days, the Food and Drug Administration (FDA) has granted emergency use authorization for an investigational antiviral pill to treat COVID-19. This time it is Merck's molnupiravir.
Dec 30, 2021
0
7